Meeting Report

Lung Cancer Biomarker Speak: Teach Me the Language

Beth Sandy,(1) MSN, CRNP, and Jennifer Morrissette,(2) PhD, FACMG

From (1)Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; (2)Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Presenters’ disclosures of conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2022;13(3):302–305 | https://doi.org/10.6004/jadpro.2022.13.3.24 | © 2022 Harborside™


  

ABSTRACT

A vital role of the advanced practitioner is to analyze biomarker testing reports and explain to patients how the results may impact their treatment. At JADPRO Live Virtual 2021, presenters reviewed the importance of molecular testing in non–small cell lung cancer and how to interpret molecular pathology reports.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.